The Use of Chorionic Gonadotropin Hormone in the Treatment of Obesity A Double-Blind Study
Open Access
- 1 March 1964
- journal article
- research article
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 14 (3) , 133-136
- https://doi.org/10.1093/ajcn/14.3.133
Abstract
A double-blind study was conducted on twenty-seven men and twenty-one women in order to determine the effect of chorionic gonadotropin hormone treatment on the obese outpatient. While subsisting on a 1,030 calorie diet, twenty-four subjects received 200 I.U. of gonadotropin three times a week, and twenty-four subjects received a placebo injection of the same volume. The mean weight loss of the group treated with the hormone was 12.3 pounds and of the control group 11.5 pounds. There was no significant difference in weight loss, subjective symptoms of hunger or body measurements between the two groups.Keywords
This publication has 7 references indexed in Scilit:
- Chorionic Gonadotropin in the Treatment of Obese WomenThe American Journal of Clinical Nutrition, 1963
- CHORIONIC GONADOTROPHIN IN THE OBESEThe Lancet, 1962
- CHORIONIC GONADOTROPHIN IN THE OBESEThe Lancet, 1961
- TREATMENT OF OVERWEIGHT PATIENTS WITH CHORIONIC GONADOTROPINJournal of the American Geriatrics Society, 1961
- A Forty-Day550 Calorie Diet in the Treatment of Obese OutpatientsThe American Journal of Clinical Nutrition, 1959
- CHORIONIC GONADOTROPIN IN GERIATRICSJournal of the American Geriatrics Society, 1956
- THE ACTION OF CHORIONIC GONADOTROPHIN IN THE OBESEThe Lancet, 1954